Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital — Chelsea, Michigan

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital is a clinical research site located in Chelsea, Michigan, United States 48118.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has participated in 208 clinical trials with 176 currently active.

Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chelsea

Browse all research sites in Michigan · View every site in Chelsea

• Trinity Health IHA Hematology Oncology Consultants-Chelsea Hospital
• Chelsea Hospital
• Saint Joseph Mercy Hospital - Chelsea
• University of Michigan / Chelsea Health Center
• Chelsea Community Hospital
• St. Joseph Health System Chelsea Hospital
• Saint Joseph Mercy Chelsea
• IHA Hematology Oncology Consultants-Chelsea
• Research Site
• IHA Chelsea Family & Internal Medicine
• St Joseph Mercy-Chelsea

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital?

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital conducted?

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has 208 clinical trials on record, with 176 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7.

Is Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital accredited by Crixeo Clinical Trials?

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.